The Division of Nuclear Medicine and Nuclear Medicine at Stanford HealthCare is rapidly expanding its clinical and research activities. Stanford has 4 PET/CT and 2 PET/MRI systems, with more growth expected. In addition to routine FDG, NaF, NH3 and amyloid PET imaging, we offer DOTA-TATE PET for neuroendocrine tumors, as well as PSMA and bombesin PET for comprehensive prostate cancer imaging.

Our Fellows

Andrei Iagaru, MD
Division of Nuclear Medicine & Molecular Imaging Chief

Fellowship Program Director

Fellowship Programs